EGFR c.2095_2096inv ;(p.P699G)

Variant ID: 7-55241647-CC-GG

NM_005228.3(EGFR):c.2095_2096inv;(p.P699G)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization.

Cancer Research
Cho, Jeonghee J; Chen, Liang L; Sangji, Naveen N; Okabe, Takafumi T; Yonesaka, Kimio K; Francis, Joshua M JM; Flavin, Richard J RJ; Johnson, William W; Kwon, Jihyun J; Yu, Soyoung S; Greulich, Heidi H; Johnson, Bruce E BE; Eck, Michael J MJ; Jänne, Pasi A PA; Wong, Kwok-Kin KK; Meyerson, Matthew M
Publication Date: 2013-11-15

Variant appearance in text: EGFR: P699G
PubMed Link: 24063894
Variant Present in the following documents:
  • Main text
View BVdb publication page